Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI109765

Interaction of Fat-stimulated Gastric Inhibitory Polypeptide on Pancreatic Alpha and Beta Cell Function

C. A. Verdonk, R. A. Rizza, R. L. Nelson, V. L. W. Go, J. E. Gerich, and F. J. Service

Endocrine Research Unit, Gastroenterology Research Unit, Department of Medicine, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55901

Endocrine Research Unit, Gastroenterology Research Unit, Department of Physiology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55901

Find articles by Verdonk, C. in: PubMed | Google Scholar

Endocrine Research Unit, Gastroenterology Research Unit, Department of Medicine, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55901

Endocrine Research Unit, Gastroenterology Research Unit, Department of Physiology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55901

Find articles by Rizza, R. in: PubMed | Google Scholar

Endocrine Research Unit, Gastroenterology Research Unit, Department of Medicine, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55901

Endocrine Research Unit, Gastroenterology Research Unit, Department of Physiology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55901

Find articles by Nelson, R. in: PubMed | Google Scholar

Endocrine Research Unit, Gastroenterology Research Unit, Department of Medicine, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55901

Endocrine Research Unit, Gastroenterology Research Unit, Department of Physiology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55901

Find articles by Go, V. in: PubMed | Google Scholar

Endocrine Research Unit, Gastroenterology Research Unit, Department of Medicine, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55901

Endocrine Research Unit, Gastroenterology Research Unit, Department of Physiology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55901

Find articles by Gerich, J. in: PubMed | Google Scholar

Endocrine Research Unit, Gastroenterology Research Unit, Department of Medicine, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55901

Endocrine Research Unit, Gastroenterology Research Unit, Department of Physiology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55901

Find articles by Service, F. in: PubMed | Google Scholar

Published May 1, 1980 - More info

Published in Volume 65, Issue 5 on May 1, 1980
J Clin Invest. 1980;65(5):1119–1125. https://doi.org/10.1172/JCI109765.
© 1980 The American Society for Clinical Investigation
Published May 1, 1980 - Version history
View PDF
Abstract

Gastric inhibitory polypeptide (GIP) is considered to be the principal mediator of the enteroinsular axis. A glucose-insulin clamp technique was used to study the effects of differing blood glucose levels on the insulinotropic and glucagonotropic actions of fat-stimulated GIP in seven healthy subjects, as well as the effect of physiologic hyperinsulinemia on GIP secretion. Blood glucose levels were clamped for 4 h at 43±2 mg/dl (hypoglycemic clamp), 88±1 mg/dl (euglycemic clamp), and 141±2 mg/dl (hyperglycemic clamp) in the presence of a constant insulin infusion (100 m U/kg per h).

Under hypoglycemic clamp conditions there was no increase in C-peptide nor glucagon after Lipomul ingestion, despite an increase of GIP of 51.7±8.7 ng/ml per 120 min. Under euglycemic clamp conditions, small and inconsistent increases in C-peptide and glucagon were observed after fat ingestion and a concomitant increase of GIP of 35.2±9.4 ng/ml per 120 min. Under hyperglycemic clamp conditions after fat ingestion and a GIP increase of 24.0±5.7 ng/ml per 120 min, C-peptide increased from 6.4±5 ng/ml to 11.0±1.1 ng/ml (P < 0.01) but glucagon did not change. These findings confirm that in healthy man GIP exerts its insulinotropic properties only under hyperglycemic conditions and indicate that GIP is not glucagonotropic.

Under euglycemic clamp conditions (plasma glucose, 89±1 mg/dl) and physiologic hyperinsulinemia (serum immunoreactive insulin, 137±3 μU/ml) GIP responses to fat ingestion (39.7±9.8 ng/ml per 120 min) were not different from the GIP responses to fat ingestion in the absence of hyperinsulinemia (39.7±11.1 ng/ml per 120 min). Therefore, insulin under normoglycemic conditions does not exert an inhibitory effect on fat-stimulated GIP secretion. The higher GIP response to oral fat in the hypoglycemic clamp, and the lower GIP response in the hyperglycemic clamp compared to the response in the euglycemic clamp suggests an effect of glycemia itself on GIP secretion in the presence of hyperinsulinemia.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1119
page 1119
icon of scanned page 1120
page 1120
icon of scanned page 1121
page 1121
icon of scanned page 1122
page 1122
icon of scanned page 1123
page 1123
icon of scanned page 1124
page 1124
icon of scanned page 1125
page 1125
Version history
  • Version 1 (May 1, 1980): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts